<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:38:25Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2958310" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2958310</identifier><datestamp>2010-11-08</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="brief-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biochem Biophys Res Commun</journal-id>
      <journal-id journal-id-type="iso-abbrev">Biochem. Biophys. Res. Commun</journal-id>
      <journal-title-group>
        <journal-title>Biochemical and Biophysical Research Communications</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0006-291X</issn>
      <issn pub-type="epub">1090-2104</issn>
      <publisher>
        <publisher-name>Academic Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC2958310</article-id>
      <article-id pub-id-type="pmcid">PMC2958310</article-id>
      <article-id pub-id-type="pmc-uid">2958310</article-id>
      <article-id pub-id-type="pmid">20637728</article-id>
      <article-id pub-id-type="publisher-id">S0006-291X(10)01337-9</article-id>
      <article-id pub-id-type="doi">10.1016/j.bbrc.2010.07.035</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pancreatic and duodenal homeobox 1 (PDX1) phosphorylation at serine-269 is HIPK2-dependent and affects PDX1 subnuclear localization</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>An</surname>
            <given-names>Rong</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="fn1" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>da Silva Xavier</surname>
            <given-names>Gabriela</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="fn1" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Semplici</surname>
            <given-names>Francesca</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="fn1" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vakhshouri</surname>
            <given-names>Saharnaz</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hao</surname>
            <given-names>Huai-Xiang</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rutter</surname>
            <given-names>Jared</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pagano</surname>
            <given-names>Mario A.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meggio</surname>
            <given-names>Flavio</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinna</surname>
            <given-names>Lorenzo A.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rutter</surname>
            <given-names>Guy A.</given-names>
          </name>
          <email>g.rutter@imperial.ac.uk</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="cor1" ref-type="corresp">â</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Section of Cell Biology, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London SW7 2AZ, UK</aff>
      <aff id="aff2"><label>b</label>Department of Biochemistry, University of Utah, Salt Lake City, UT 84112-5650, USA</aff>
      <aff id="aff3"><label>c</label>Department of Biological Chemistry, University of Padova, viale G. Colombo 3, 35131 Padova, Italy</aff>
      <author-notes>
        <corresp id="cor1"><label>â</label>Corresponding author. Address: Department of Medicine, Imperial College London, Exhibition Road, London SW7 2AZ, UK. Fax: +44 020 7594 3351. <email>g.rutter@imperial.ac.uk</email></corresp>
        <fn id="fn1">
          <label>1</label>
          <p>These authors contributed equally to the work described in this manuscript.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>20</day>
        <month>8</month>
        <year>2010</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <day>20</day>
        <month>8</month>
        <year>2010</year>
      </pub-date>
      <volume>399</volume>
      <issue>2</issue>
      <fpage>155</fpage>
      <lpage>161</lpage>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>6</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2010 Elsevier Inc.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license xlink:href="https://creativecommons.org/licenses/by/3.0/">
          <license-p>Open Access under <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/3.0/">CC BY 3.0</ext-link> license</license-p>
        </license>
      </permissions>
      <abstract abstract-type="graphical">
        <title>Research highlights</title>
        <p>âº Mouse PDX1 Ser-269 is phosphorylated in pancreatic islets of Langerhans and beta cells. âº High glucose concentration decreases the degree of phosphorylation on PDX1 Ser-269, as assessed by a phospho-specific anti-phospho-Ser269 antibody. âº HIPK2 is a potential kinase for PDX1 Ser-269. âº Phosphorylation at Ser-269 affects the subnuclear distribution of PDX1.</p>
      </abstract>
      <abstract>
        <p>Pancreatic and duodenal homeobox 1 (PDX1) regulates pancreatic development and mature Î²-cell function. We demonstrate by mass spectrometry that serine residue at position 269 in the C-terminal domain of PDX1 is phosphorylated in Î²-cells. Besides we show that the degree of phosphorylation, assessed with a phospho-Ser-269-specific antibody, is decreased by elevated glucose concentrations in both MIN6 Î²-cells and primary mouse pancreatic islets. Homeodomain interacting protein kinase 2 (HIPK2) phosphorylates PDX1 <italic>in vitro</italic>; phosphate incorporation substantially decreases in PDX1 S269A mutant. Silencing of HIPK2 led to a 51Â Â±Â 0.2% decrease in Ser-269 phosphorylation in MIN6 Î²-cells. Mutation of Ser-269 to phosphomimetic residue glutamic acid (S269E) or de-phosphomimetic residue alanine (S269A) exerted no effect on PDX1 half-life. Instead, PDX1 S269E mutant displayed abnormal changes in subnuclear localization in response to high glucose. Our results suggest that HIPK2-mediated phosphorylation of PDX1 at Ser-269 might be a regulatory mechanism connecting signals generated by changes in extracellular glucose concentration to downstream effectors via changes in subnuclear localization of PDX1, thereby influencing islet cell differentiation and function.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>PDX1</kwd>
        <kwd>Islet</kwd>
        <kwd>Î²-Cell</kwd>
        <kwd>Phosphorylation</kwd>
        <kwd>Glucose</kwd>
        <kwd>HIPK2</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <label>1</label>
      <title>Introduction</title>
      <p>Control by glucose of preproinsulin gene transcription in pancreatic islet Î²-cells involves the interplay of multiple <italic>trans</italic>- and <italic>cis</italic>-activating factors (<xref rid="bib1" ref-type="bibr">[1]</xref> and references therein). Pancreatic and duodenal homeobox 1 (PDX1) was first described as a preproinsulin promoter A3-site binding factor <xref rid="bib2 bib3" ref-type="bibr">[2,3]</xref>. PDX1 is involved in both the development and function of pancreatic Î² and other islet cells <xref rid="bib4" ref-type="bibr">[4]</xref>.</p>
      <p>Deletion or inactivation of the <italic>PDX1</italic> gene in the mouse <xref rid="bib5" ref-type="bibr">[5]</xref> or in man <xref rid="bib6" ref-type="bibr">[6]</xref> results in the complete failure of normal pancreatic development. Moreover, Î²-cell selective disruption of murine PDX1 expression <xref rid="bib7" ref-type="bibr">[7]</xref> or function <xref rid="bib8" ref-type="bibr">[8]</xref> lead respectively to defective insulin secretion and glucose signaling. On the other hand, heterozygosity for a defective <italic>PDX1</italic> gene leads to defective preproinsulin gene expression <xref rid="bib7" ref-type="bibr">[7]</xref> and abnormal insulin secretion <xref rid="bib9" ref-type="bibr">[9]</xref> in mice and to maturity-onset-diabetes of the young 4 (MODY4) in man <xref rid="bib6" ref-type="bibr">[6]</xref>.</p>
      <p>In contrast to the relatively well-studied functions of the N-terminus and the homeodomain of PDX1, the role of the conserved C-terminus is less well defined. Mutations which affect the C-terminus of PDX1 are associated with the development of type 2 diabetes in humans <xref rid="bib10 bib11 bib12" ref-type="bibr">[10â12]</xref>, while other findings indicate that the C-terminal domain may serve as both repressor and activator of PDX1 function <xref rid="bib13 bib14" ref-type="bibr">[13,14]</xref>.</p>
      <p>Humphrey and colleagues <xref rid="bib15" ref-type="bibr">[15]</xref> reported that PDX1 phosphorylation in primary rat islets is decreased by high glucose levels. These authors described Ser-268 and Ser-272 of rat PDX1 (corresponding to Ser-269 and Ser-273 of mouse PDX1) as a novel C-terminal atypical non-primed GSK-3 consensus site which regulates PDX1 protein stability in response to glucose. Importantly, homeodomain interacting protein kinase 2 (HIPK2) (<xref rid="bib16" ref-type="bibr">[16]</xref> and references therein) has been shown to co-localize with PDX1 in both the developing and adult pancreas and to modulate positively PDX1 transcriptional activity, possibly by phosphorylation of the C-terminal domain <xref rid="bib17" ref-type="bibr">[17]</xref>. We have previously observed that, in clonal Î²-cells, elevated glucose concentrations lead to translocation of PDX1 between the nuclear periphery and the nucleoplasm, accompanied by increased preproinsulin promoter activity <xref rid="bib18" ref-type="bibr">[18]</xref>. Although the molecular basis for the enhanced nucleoplasmic accumulation of PDX1 is unclear, this process may involve interaction of PDX1 homeodomain with the nuclear import receptor family member importin-Î²1 <xref rid="bib19" ref-type="bibr">[19]</xref>. In the present study we used mass spectrometry and generated an anti-phospho-serine-specific antibody to confirm Ser-269 as a <italic>bona fide</italic> phosphorylation site in mouse PDX1 that is regulated by glucose in MIN6 Î²-cells and in primary mouse islets of Langerhans. We show that Ser-269 is phosphorylated by homeodomain interacting protein kinase 2 (HIPK2) <italic>in vitro.</italic> The analysis of (de)phospho-Ser-269-specific mutants suggest that phosphorylation at this site, whilst having no effect on PDX1 protein stability or PDX1 DNA-binding property, is involved in nucleoplasmic (versus nuclear-peripheric) localization in the Î²-cell in response to glucose.</p>
    </sec>
    <sec sec-type="materials|methods">
      <label>2</label>
      <title>Materials and methods</title>
      <p>The work described in this article has been carried out in accordance with the <italic>EC Directive 86/609/EEC for animal experiments</italic>
<ext-link ext-link-type="uri" xlink:href="http://europa.eu.int/scadplus/leg/en/s23000.htm">http://europa.eu.int/scadplus/leg/en/s23000.htm</ext-link>; and the <italic>Uniform Requirements for manuscripts submitted to Biomedical journals</italic>
<ext-link ext-link-type="uri" xlink:href="http://www.nejm.org/general/text/requirements/1.htm">http://www.nejm.org/general/text/requirements/1.htm</ext-link>.</p>
      <sec>
        <label>2.1</label>
        <title>Cell culture and reagents</title>
        <p>Human embryonic kidney (HEK) 293 cells were cultured in Dulbeccoâs modified Eagleâs medium (DMEM) (Lonza) containing 10% (v/v) fetal bovine serum (FBS), 100Â IU/ml penicillin and 100Â IU/ml streptomycin. INS-1(832/13) cells (kindly provided by Dr. C. Newgard, Duke University) and MIN6 Î² (mouse insulinoma pancreatic beta) cells were cultured as in <xref rid="bib20" ref-type="bibr">[20]</xref>.</p>
        <p>Anti-<italic>c-myc</italic> antibody was from Roche. Rabbit polyclonal anti-PDX1 antibody was as described <xref rid="bib18" ref-type="bibr">[18]</xref>. Anti-phospho-Ser-269-PDX1 antibody was raised in rabbits by immunization with synthetic phospho-peptide: L<sup>262</sup>PSGLSV<bold>pS</bold>PQPSSIAPLRPQEPR<sup>284</sup> (Pacific Immunology Inc, USA). HIPK2 was purchased from Upstate (Lake Placid, NY).</p>
      </sec>
      <sec>
        <label>2.2</label>
        <title>Mouse islet isolation and culture</title>
        <p>Islets were isolated from CD1 mice and cultured as previously described <xref rid="bib21" ref-type="bibr">[21]</xref>.</p>
      </sec>
      <sec>
        <label>2.3</label>
        <title>Plasmids</title>
        <p>Plasmid pcDNA3-PDX1-<italic>c-myc</italic> has been described <xref rid="bib18" ref-type="bibr">[18]</xref>. Mutant plasmids pcDNA3-PDX1-S269A<italic>-c</italic>-<italic>myc</italic> and pcDNA3-PDX1-S269E<italic>-c-myc</italic> were generated using a QuikChange site-directed mutagenesis kit (Stratagene). Wild-type and mutant PDX1 myc-tagged coding sequences were inserted (<italic>Hind</italic>III/<italic>Eco</italic>RV) into the shuttle vector pAdTrack-CMV multiple cloning site <xref rid="bib22" ref-type="bibr">[22]</xref>. Mouse wild-type PDX1 sequence PCR amplified from plasmid pcDNA3-PDX1-<italic>c-myc</italic> was cloned (<italic>Nco</italic>I/<italic>Bam</italic>HI) into 6xHis-MBP (maltose binding protein) plasmid. Mutant plasmid His-MBP-PDX1 (S269A) was generated as above.</p>
      </sec>
      <sec>
        <label>2.4</label>
        <title>His-MBP-PDX1 production and purification</title>
        <p>His-MBP-PDX1 proteins expression was induced in <italic>Escherichia coli</italic> BL21 with 0.2Â mM isopropyl-Î²-<sc>d</sc>-thiogalactopyranoside (IPTG). Proteins were purified on a nickelânitrilotriacetic acid column according to Qiagen and dialyzed for 16Â h at 4Â Â°C in 50Â mM Tris pH 7.9, 150Â mM NaCl, 5Â mM MgCl<sub>2</sub>, 1Â mM Î²-mercaptoethanol. The MBP moiety was cut with Tobacco Etch Virus (TEV) protease, AcTEV<sup>TM</sup> protease (Invitrogen). MBP, histidine tag and histidine-tagged Ac-TEV protease were removed respectively with Amylose beads (New England BioLab) and NiâNTA agarose beads.</p>
      </sec>
      <sec>
        <label>2.5</label>
        <title>Recombinant adenoviruses and viral infection</title>
        <p>Recombinant adenoviruses expressing wild-type (WT) and mutant (S269A, S269E) PDX1 and control adenovirus, expressing green fluorescent protein (Ad-GFP) were prepared using the AdEasy system <xref rid="bib22" ref-type="bibr">[22]</xref>. Cells were infected with various adenoviruses at a multiplicity of infection (MOI) of 50 for 5Â h and maintained in 25Â mM glucose for 24Â h before subsequent experiments.</p>
      </sec>
      <sec>
        <label>2.6</label>
        <title>Real-time RT-PCR</title>
        <p>Total mRNA and real-time quantitative RT-PCR analysis was as <xref rid="bib23" ref-type="bibr">[23]</xref>. Primer sequences are as follows: cyclophilin A fwd, 5â²-TAT CTG CAC TGC CAA GAC TGA-3â²; cyclophilin A rev, 5â²-CCA CAA TGC TCA TGC CTT CTT TCA-3â²; HIPK2 fwd, 5â²-TGC TTG ACT TCC CCC ATA GTG -3â²; HIPK2 rev, 5â²-CTT GCA AAT CTC CAT GTT TTG G -3â².</p>
        <p>Data were analyzed by ABR PRISM SDS v1.3.1 (Applied Biosystems).</p>
      </sec>
      <sec>
        <label>2.7</label>
        <title>Immunocytochemistry</title>
        <p>MIN6 Î²-cells infected with wild-type or mutant forms of PDX1 viruses at 50 MOI (multiplicity of infection). Immunocytochemical analysis was performed as described in the figure legends and in <xref rid="bib20" ref-type="bibr">[20]</xref>.</p>
      </sec>
      <sec>
        <label>2.8</label>
        <title>Immunoprecipitation</title>
        <p>Cells lyzed on ice with 750Â Î¼l of IP buffer [1% (v/v) NP40 (Nonidet P40); 50Â mM NaCl; 1% (w/v) sodium deoxycholate; 0.1% (w/v) sodium monododecyl sulfate (SDS); 50Â mM TrisâHCl pH 7.5; 2Â mM EDTA; 10Â mM sodium phosphate; 50Â mM NaF (sodium fluoride); 1Â m PMSF; 200Â Î¼M Na<sub>3</sub>VO<sub>4</sub> (sodium orthovanadate); 1Â ÃÂ Complete<sup>TM</sup> protease inhibitor cocktail solution (Roche) and 1Â ÃÂ phosphatase inhibitor cocktail 1 &amp; 2 (Sigma)] were rotated on wheel at 4Â Â°C for 30Â min. The lysate was clarified by centrifugation at 16,000<italic>g</italic> for 5Â min. <italic>c-myc</italic> antibody-conjugated beads (Santa-Cruz; 40Â Î¼l) were added and tubes rotated at 4Â Â°C overnight. After centrifugation at 1,000<italic>g</italic> at 4Â Â°C for 30Â s, beads were washed five times with lysis buffer.</p>
      </sec>
      <sec>
        <label>2.9</label>
        <title><italic>In vitro</italic> phosphorylation by HIPK2</title>
        <p>Purified wild-type (WT) or serine to alanine mutant (S269A) PDX1 (2Â Î¼g) was subjected to <italic>in vitro</italic> phosphorylation with HIPK2 (Upstate) following the manufacturerâs instruction.</p>
      </sec>
      <sec>
        <label>2.10</label>
        <title>Western blotting</title>
        <p>Nuclear proteins were extracted as in <xref rid="bib24" ref-type="bibr">[24]</xref>. Protein samples were separated on SDSâPAGE, and analyzed by Western blotting with the indicated antibodies.</p>
      </sec>
      <sec>
        <label>2.11</label>
        <title>Silencing of HIPK2</title>
        <p>siRNA were made with the AMBION Silencer siRNA construction kit. Starting primer pairs were designed as suggested in the AMBION protocol and according to the guidelines published in <xref rid="bib25" ref-type="bibr">[25]</xref>. Sense and anti-sense primers were derived from mouse cDNA sequence for HIPK2 in the ENSEMBL database (transcript name: Hipk2-201; transcript Id: ENSMUST00000038777). Target sequence was from nucleotide 788 to nucleotide 808 as follows: 5â²-AAA CGG GGC ACC AAT GAA ATT CCT GTC TC-3â²). Control siRNA were made with primers derived by scrambling the siRNA sequence for HIPK2. All sequences were searched against known mouse cDNA sequences using BLAST (<ext-link ext-link-type="uri" xlink:href="http://blast.ncbi.nlm.nih.gov/Blast.cgi">http://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>). Transfection was with TransIT-TKO transfection reagent (Mirus Bio Corporation).</p>
      </sec>
      <sec>
        <label>2.12</label>
        <title>Pulse-chase</title>
        <p>MIN6 Î²-cells were infected with PDX1 wild-type, S269A and S269E adenoviruses. 24Â h after infection, media were replaced with fresh DMEM containing 3Â mM glucose and cells were cultured for 16Â h. Cells were transferred for 1Â h to cysteine/methionine-free medium, pulsed for 3Â h with 0.6Â mCi [<sup>35</sup>S]cysteine/methionine (PerkinâElmer), after which cells were washed and cultured for 2, 4, 8, and 16Â h in 5Â ml chase media with 10,000-fold molar excess of cold <sc>l</sc>-cysteine, <sc>l</sc>-methionine or harvested as the zero time point. Cells were lyzed in 1Â ml RIPA [50Â mM Tris (pH 7.5), 150Â mM NaCl, 1% (v/v) Nonidet P-40 (NP-40) 0.5% (w/v) sodium deoxycholate (DOC), 0.1% (v/v) SDS, 0.4Â mg/ml AESBF {4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride}, 10Â Î¼g/ml Leupeptin, 10Â Î¼g/ml Pepstatin, 5Â Î¼g/ml Aprotinin, 1Â ÃÂ Complete<sup>TM</sup> (Roche) and 1Â ÃÂ phosphatase inhibitor cocktail 1 and 2 (Sigma)]. Lysates were immunoprecipitated with anti-myc antibody (Roche). After five washes with RIPA buffer, proteins were eluted and analyzed by SDSâPAGE. PDX1 proteins were detected by fluorography and quantified in a Cyclone (PerkinâElmer) phosphoimager storage system.</p>
      </sec>
      <sec>
        <label>2.13</label>
        <title>Statistics</title>
        <p>Data are given as means Â±SE of three to five individual experiments. Comparisons between means were performed using one-tailed Studentâs <italic>t</italic>-test for paired data with Bonferroni correction for multiple sampling as appropriate.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <label>3</label>
      <title>Results</title>
      <sec>
        <label>3.1</label>
        <title>Ser-269 phosphorylation is regulated by glucose in living Î²-cells (MIN6) and primary mouse islets</title>
        <p>PDX1 Ser-269 was identified as a potential phosphorylation site by mass spectrometry (<xref rid="app1" ref-type="sec">Supplementary Fig. 1</xref>). We, therefore, explored the possibility that phosphorylation of PDX1 at Ser-269 may be regulated by glucose in living Î²-cells and, thus, may, at least potentially, contribute to the regulation of PDX1 function by the sugar. After treatment at low glucose concentrations (3Â mM) for 16 (MIN6 Î²-cells) or 1Â h (islets), we further incubated islets (<xref rid="fig1" ref-type="fig">Fig. 1</xref>A) or MIN6 Î²-cells (<xref rid="fig1" ref-type="fig">Fig. 1</xref>B) in medium containing 16.7 or 30Â mM glucose, respectively, for varying times.</p>
        <p>Examined in mouse islets, the nuclear content of phosphorylated Ser-269-PDX1 decreased following culture for 1Â h at 16.7Â mM glucose (<xref rid="fig1" ref-type="fig">Fig. 1</xref>A). In MIN6 Î²-cells, as early as 30Â min after the change in glucose concentration, cells maintained at 30Â mM glucose displayed a markedly lower degree of phosphorylation at Ser-269 PDX1 (<xref rid="fig1" ref-type="fig">Fig. 1</xref>B). This difference increased, with enhanced phosphorylation at Ser-269, during the subsequent 24Â h.</p>
      </sec>
      <sec>
        <label>3.2</label>
        <title>HIPK2 phosphorylation of PDX1</title>
        <p>Homeodomain interacting protein kinase 2 (HIPK2) was previously reported to phosphorylate the C-terminal domain of PDX1 at undefined site(s) lying between amino acids 215 and 283 <xref rid="bib17" ref-type="bibr">[17]</xref>. Since HIPK2 is a proline-directed kinase <xref rid="bib17" ref-type="bibr">[17]</xref>, and Ser-269 is adjacent to a proline residue, we investigated whether Ser-269 may be phosphorylated by HIPK2 <italic>in vitro</italic>. This possibility was examined using active HIPK2 and recombinant <italic>c-myc</italic>-tagged wild-type or S269A PDX1 as substrates (<xref rid="fig2" ref-type="fig">Fig. 2</xref>). Wild-type PDX1 incorporated [<sup>32</sup>P] proportionately with increasing concentration of HIPK2, in agreement with the previous study <xref rid="bib17" ref-type="bibr">[17]</xref> (<xref rid="fig2" ref-type="fig">Fig. 2</xref>A). Furthermore, incorporation of [<sup>32</sup>P] into recombinant S269A PDX1 was substantially decreased at all levels of HIPK2 activity tested when compared to the wild-type factor (<xref rid="fig2" ref-type="fig">Fig. 2</xref>A). Parallel experiments performed with non-radioactive ATP produced an immunoreactive band at â¼46Â kDa with anti-phospho-Ser-269 PDX1 antibody for wild-type PDX1; while, as anticipated, a lack of immunoreactivity was apparent after treatment of S269A PDX1 (<xref rid="fig2" ref-type="fig">Fig. 2</xref>B).</p>
        <p>Whilst the increased signal detected with the anti-phospho-Ser-269-specific PDX1 antibody in wild-type PDX1 confirmed HIPK2 mediated phosphorylation at this site, residual incorporation of phosphate into S269A PDX1 (<xref rid="fig2" ref-type="fig">Fig. 2</xref>A) suggested the existence of additional phosphorylation sites for this kinase. Indeed, our mass spectrometry (<xref rid="app1" ref-type="sec">Supplementary Fig. 1</xref>) identified a long peptide, S<sup>211</sup>SGT<sup>214</sup>PSGGGGGEEPEQDCAVTSGEELLAVPPLPPPGGAVPPGVPAAVR that was also phosphorylated. Although the exact site of phosphorylation on this peptide was not pursued further, we noted a Thr-214 followed by a proline residue in this peptide that meets the criteria for phosphorylation by proline-directed kinases, including HIPK2.</p>
        <p>Confirming that Ser-269 phosphorylation occurs via HIPK2 in living cells, MIN6 Î²-cells in which HIPK2 was silenced by 87.5Â Â±Â 1.0% after 72Â h culture with siRNA (<xref rid="fig2" ref-type="fig">Fig. 2</xref>C), as assessed by real-time PCR analysis (a commercial antibody that recognizes endogenous HIPK2 not being available), had a 51Â Â±Â 0.2% decrease in phospho-Ser-269 PDX1 content (<xref rid="fig2" ref-type="fig">Fig. 2</xref>D) after 24Â h culture at 3Â mM glucose.</p>
      </sec>
      <sec>
        <label>3.3</label>
        <title>Phosphorylation on Ser-269 does not affect the stability of PDX1</title>
        <p>We examined the half-life of the mutants by [<sup>35</sup>S] pulse chase labeling experiments which revealed equal stability of phospho/de-phospho-Ser-269 mimetic mutants of PDX1 (<xref rid="fig3" ref-type="fig">Fig. 3</xref>). We demonstrated that wild-type <italic>c-myc</italic>-tagged-PDX1 has an estimated half-life, when over expressed in MIN6 Î²-cells, of 5Â h and 30Â min (Â±4). The turnover rates of S269A and S269E PDX1 were not significantly different from wild-type PDX1 (<xref rid="fig3" ref-type="fig">Fig. 3</xref>).</p>
      </sec>
      <sec>
        <label>3.4</label>
        <title>Phosphorylation at Ser-269 affects the subnuclear distribution of PDX1 in MIN6 Î²-cells</title>
        <p>In order to determine whether de-phosphorylation at Ser-269 at elevated glucose concentrations may contribute to the nucleoplasmic accumulation of PDX1, MIN6 Î²-cells were transduced with adenoviruses encoding c-<italic>myc</italic>-tagged wild-type, S269A or S269E mutant forms of PDX1. Cells were then cultured at either 3 or 30Â mM glucose. High glucose caused a significant redistribution both of the de-phosphomimetic mutant S269A PDX1 and wild-type PDX1 from nuclear periphery to nucleoplasm (<xref rid="fig4" ref-type="fig">Fig. 4</xref>), consistent with previous studies <xref rid="bib18" ref-type="bibr">[18]</xref>. Thus, at 30Â mM glucose wild-type PDX1 was predominantly present in the nuclear region, as was the de-phosphomimetic mutant, while the phospho-mimetic mutant displayed a different localization (nuclear periphery) as compared to wild-type PDX1.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <label>4</label>
      <title>Discussion</title>
      <p>The principal aim of this study was to elucidate the molecular mechanisms involved in the regulation by glucose and other stimuli of the nuclear uptake, DNA binding and transactivation capacities of PDX1, focusing on the potential role of protein phosphorylation.</p>
      <p>We demonstrate firstly through mass spectrometry, and by subsequent verification with a phospho-specific antibody, that Ser-269 in the C-terminal domain of PDX1 is phosphorylated in living Î²-cells, consistent with recent findings <xref rid="bib15" ref-type="bibr">[15]</xref>. We show here that Ser-269 is de-phosphorylated in response to glucose and that HIPK2 is capable of phosphorylating this residue both <italic>in vitro</italic> and <italic>in vivo</italic>. Phosphorylation of the C-terminus of PDX1 in a region encompassing Ser-269 by HIPK2 has previously been reported, although the effects of glucose on this phenomenon were not described <xref rid="bib17" ref-type="bibr">[17]</xref>. We show that the degree of phosphorylation of PDX1 at Ser-269 was decreased at elevated glucose concentrations. A detailed analysis of the possible effects of phosphorylation at the site using (de)phosphomimetic mutants failed to reveal any differences between the transactivation capacity of the wild-type protein compared to mutants bearing A or E in place of S269 (<xref rid="app1" ref-type="sec">Supplementary Fig. 4</xref>). These observations, together with the analysis of the subnuclear localization of WT, S269A and S269E PDX1 in MIN6 Î²-cells (<xref rid="fig4" ref-type="fig">Fig. 4</xref>), suggest that HIPK2 phosphorylation of PDX1 regulates PDX1 function via the regulation of its subnuclear localization but not its transactivation potential.</p>
      <p>HIPK2 regulates gene expression by phosphorylation of transcription factors (including p53, Pax6, Myb) and accessory components of the transcription machinery (among others p300, CtBP1) (<xref rid="bib16" ref-type="bibr">[16]</xref> and references therein). A recent study reported that HIPK2 is expressed in the developing pancreatic epithelium from embryonic day e12 to e15 but that the expression becomes preferentially confined to pancreatic endocrine cells at later developmental stages <xref rid="bib17" ref-type="bibr">[17]</xref>. Moreover, HIPK2 was reportedly able to modulate positively the protein content and transcriptional activity of PDX1, and directly phosphorylate the C-terminal portion of PDX1 <xref rid="bib17" ref-type="bibr">[17]</xref>. Our data now provide evidence that HIPK2 may be involved in the regulation of PDX1 function in living Î²-cells through phosphorylation of Ser-269 and regulation of the subnuclear distribution of PDX1. Boucher and colleagues <xref rid="bib17" ref-type="bibr">[17]</xref> observed an increase of PDX1 transcriptional activity and protein levels upon cotransfection of HEK 293 cells with a plasmid overexpressing HIPK2. By contrast, we were not able in the present studies to detect major changes of PDX1 transcriptional activity upon mutation of serine-269 to a phospho- (glutamic acid) or de-phospho- (alanine) mimetic residue, at least when examined in a heterologous expression system, HEK293 cells (<xref rid="app1" ref-type="sec">Supplementary Fig. 4</xref>). Importantly, in this cellular context, we have not been able to observe effects of glucose on the subnuclear localization of PDX1 (results not shown) suggesting that such changes, as observed in the Î²-cell, may be the principal route through which changes in Ser269 phosphorylation impact on PDX1 function in the latter context. A further possibility is that HIPK2 is able, as we observed <italic>in vitro</italic>, to phosphorylate PDX1 on more than one site besides serine-269. In fact, the mass spectrometry analysis that we performed on PDX1 overexpressed and immunoprecipitated from clonal Î²-cells has confirmed that peptide <sup>211</sup><bold>SS</bold>G<bold>T</bold>P<bold>S</bold>GGGGGEEPEQDCAV<bold>TS</bold>GEELLAVPPLPPPGGAVPPGVPAAVR<sup>258</sup> bears at least one phosphate group as earlier observed by Boucher and colleagues <xref rid="bib17" ref-type="bibr">[17]</xref>. Threonine-214 in this peptide is a likely candidate target for phosphorylation by HIPK2.</p>
      <p>In contrast to earlier studies <xref rid="bib15" ref-type="bibr">[15]</xref> we did not observe differences in stability between wild-type and mutant (Ser-269) PDX1. One significant protocol difference between the present and earlier studies is that we have analyzed more time points, allowing a more precise determination of the half-life. Importantly, the calculated half-life based on our protocol was shorter, at 5Â h and 30Â min (Â±4Â min), than the previously reported âapproximately 8Â hâ <xref rid="bib15" ref-type="bibr">[15]</xref>. Also, treatment of Î²-cells with 100Â Î¼g/ml cycloheximide, as undertaken by Humphrey and colleagues, might have affected cellular metabolism and hence protein turnover.</p>
    </sec>
    <sec sec-type="conclusions">
      <label>5</label>
      <title>Conclusion</title>
      <p>Our data provide evidence that serine 269 in mouse PDX1 is phosphorylated in living pancreatic Î²-cells, as revealed through the use of mass spectrometry and confirmed by the generation of a phosphoserine-specific antibody. We also show that this event affects the subnuclear localization of PDX1 in Î²-cells.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andrali</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Sampley</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Vanderford</surname>
              <given-names>N.L.</given-names>
            </name>
            <name>
              <surname>Ozcan</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Glucose regulation of insulin gene expression in pancreatic beta-cells</article-title>
          <source>Biochem. J.</source>
          <volume>415</volume>
          <year>2008</year>
          <fpage>1</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="pmid">18778246</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melloul</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ben-Neriah</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Cerasi</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>90</volume>
          <year>1993</year>
          <fpage>3865</fpage>
          <lpage>3869</lpage>
          <pub-id pub-id-type="pmid">8483904</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohlsson</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Karlsson</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Edlund</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>IPF1 a homeodomain-containing transactivator of the insulin gene</article-title>
          <source>EMBO J.</source>
          <volume>12</volume>
          <year>1993</year>
          <fpage>4251</fpage>
          <lpage>4259</lpage>
          <pub-id pub-id-type="pmid">7901001</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>C.P.</given-names>
            </name>
            <name>
              <surname>McGehee</surname>
              <given-names>R.E.</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Habener</surname>
              <given-names>J.F.</given-names>
            </name>
          </person-group>
          <article-title>IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene</article-title>
          <source>EMBO J.</source>
          <volume>13</volume>
          <year>1994</year>
          <fpage>1145</fpage>
          <lpage>1156</lpage>
          <pub-id pub-id-type="pmid">7907546</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jonsson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Carlsson</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Edlund</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Edlund</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Insulin-promoter-factor 1 is required for pancreas development in mice</article-title>
          <source>Nature</source>
          <volume>371</volume>
          <year>1994</year>
          <fpage>606</fpage>
          <lpage>609</lpage>
          <pub-id pub-id-type="pmid">7935793</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stoffers</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Zinkin</surname>
              <given-names>N.T.</given-names>
            </name>
            <name>
              <surname>Stanojevic</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>W.L.</given-names>
            </name>
            <name>
              <surname>Habener</surname>
              <given-names>J.F.</given-names>
            </name>
          </person-group>
          <article-title>Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence</article-title>
          <source>Nat. Genet.</source>
          <volume>15</volume>
          <year>1997</year>
          <fpage>106</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">8988180</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahlgren</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Jonsson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Jonsson</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Simu</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Edlund</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Beta-cell-specific inactivation of the mouse Ipf1/<italic>PDX1</italic> gene results in loss of the beta-cell phenotype and maturity onset diabetes</article-title>
          <source>Genes Dev.</source>
          <volume>12</volume>
          <year>1998</year>
          <fpage>1763</fpage>
          <lpage>1768</lpage>
          <pub-id pub-id-type="pmid">9637677</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>N.T.</given-names>
            </name>
            <name>
              <surname>Luciani</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Misler</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Edlund</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Polonsky</surname>
              <given-names>K.S.</given-names>
            </name>
          </person-group>
          <article-title>Increased islet apoptosis in PDX1 mice</article-title>
          <source>J. Clin. Invest.</source>
          <volume>111</volume>
          <year>2003</year>
          <fpage>1147</fpage>
          <lpage>1160</lpage>
          <pub-id pub-id-type="pmid">12697734</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brissova</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Shiota</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nicholson</surname>
              <given-names>W.E.</given-names>
            </name>
            <name>
              <surname>Gannon</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Knobel</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Piston</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>C.V.</given-names>
            </name>
            <name>
              <surname>Powers</surname>
              <given-names>A.C.</given-names>
            </name>
          </person-group>
          <article-title>Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion</article-title>
          <source>J. Biol. Chem.</source>
          <volume>277</volume>
          <year>2002</year>
          <fpage>11225</fpage>
          <lpage>11232</lpage>
          <pub-id pub-id-type="pmid">11781323</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hani</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Stoffers</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Chevre</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Durand</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Stanojevic</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Dina</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Habener</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Froguel</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus</article-title>
          <source>J. Clin. Invest.</source>
          <volume>104</volume>
          <year>1999</year>
          <fpage>R41</fpage>
          <lpage>R48</lpage>
          <pub-id pub-id-type="pmid">10545531</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weng</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Macfarlane</surname>
              <given-names>W.M.</given-names>
            </name>
            <name>
              <surname>Lehto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>H.F.</given-names>
            </name>
            <name>
              <surname>Shepherd</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Ivarsson</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Wibell</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Groop</surname>
              <given-names>L.C.</given-names>
            </name>
          </person-group>
          <article-title>Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations</article-title>
          <source>Diabetologia</source>
          <volume>44</volume>
          <year>2001</year>
          <fpage>249</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="pmid">11270685</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Desai</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Stoffers</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>Identification of PCIF1, a POZ domain protein that inhibits PDX-1 (MODY4) transcriptional activity</article-title>
          <source>Mol. Cell Biol.</source>
          <volume>24</volume>
          <year>2004</year>
          <fpage>4372</fpage>
          <lpage>4383</lpage>
          <pub-id pub-id-type="pmid">15121856</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Habener</surname>
              <given-names>J.F.</given-names>
            </name>
          </person-group>
          <article-title>Functional regions of the homeodomain protein IDX-1 required for transactivation of the rat somatostatin gene</article-title>
          <source>Endocrinology</source>
          <volume>137</volume>
          <year>1996</year>
          <fpage>2959</fpage>
          <lpage>2967</lpage>
          <pub-id pub-id-type="pmid">8770920</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peers</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Leonard</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Teitelman</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Montminy</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1</article-title>
          <source>Mol. Endocrinol.</source>
          <volume>8</volume>
          <year>1994</year>
          <fpage>1798</fpage>
          <lpage>1806</lpage>
          <pub-id pub-id-type="pmid">7708065</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Humphrey</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Flores</surname>
              <given-names>L.E.</given-names>
            </name>
            <name>
              <surname>Jhala</surname>
              <given-names>U.S.</given-names>
            </name>
          </person-group>
          <article-title>Glucose regulates steady-state levels of PDX1 via the reciprocal actions of GSK3 and Akt kinases</article-title>
          <source>J. Biol. Chem.</source>
          <volume>285</volume>
          <year>2009</year>
          <fpage>3406</fpage>
          <lpage>3416</lpage>
          <pub-id pub-id-type="pmid">19833727</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rinaldo</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Prodosmo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Siepi</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Soddu</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>HIPK2: a multitalented partner for transcription factors in DNA damage response and development</article-title>
          <source>Biochem. Cell Biol.</source>
          <volume>85</volume>
          <year>2007</year>
          <fpage>411</fpage>
          <lpage>418</lpage>
          <pub-id pub-id-type="pmid">17713576</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boucher</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Simoneau</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Edlund</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>The homeodomain-interacting protein kinase 2 regulates insulin promoter factor-1/pancreatic duodenal homeobox-1 transcriptional activity</article-title>
          <source>Endocrinology</source>
          <volume>150</volume>
          <year>2009</year>
          <fpage>87</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">18772243</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rafiq</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Rutter</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>Glucose-dependent translocation of insulin promoter factor-1 (IPF-1) between the nuclear periphery and the nucleoplasm of single MIN6 beta-cells</article-title>
          <source>J. Biol. Chem.</source>
          <volume>273</volume>
          <year>1998</year>
          <fpage>23241</fpage>
          <lpage>23247</lpage>
          <pub-id pub-id-type="pmid">9722555</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guillemain</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>da Silva Xavier</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rafiq</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Leturque</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rutter</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>Importin beta1 mediates the glucose-stimulated nuclear import of pancreatic and duodenal homeobox-1 in pancreatic islet beta-cells (MIN6)</article-title>
          <source>Biochem. J.</source>
          <volume>378</volume>
          <year>2004</year>
          <fpage>219</fpage>
          <lpage>227</lpage>
          <pub-id pub-id-type="pmid">14632628</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>da Silva Xavier</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Loder</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Tarasov</surname>
              <given-names>A.I.</given-names>
            </name>
            <name>
              <surname>Carzaniga</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kronenberger</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Barg</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Rutter</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>TCF7L2 regulates late events in insulin secretion from pancreatic islet beta cells</article-title>
          <source>Diabetes</source>
          <volume>58</volume>
          <year>2009</year>
          <fpage>894</fpage>
          <lpage>905</lpage>
          <pub-id pub-id-type="pmid">19168596</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ravier</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Rutter</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells</article-title>
          <source>Diabetes</source>
          <volume>54</volume>
          <year>2005</year>
          <fpage>1789</fpage>
          <lpage>1797</lpage>
          <pub-id pub-id-type="pmid">15919801</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>Z.L.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>W.X.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sharff</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Luu</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Haydon</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Kinzler</surname>
              <given-names>K.W.</given-names>
            </name>
            <name>
              <surname>Vogelstein</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>T.C.</given-names>
            </name>
          </person-group>
          <article-title>A protocol for rapid generation of recombinant adenoviruses using the AdEasy system</article-title>
          <source>Nat. Protoc.</source>
          <volume>2</volume>
          <year>2007</year>
          <fpage>1236</fpage>
          <lpage>1247</lpage>
          <pub-id pub-id-type="pmid">17546019</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parton</surname>
              <given-names>L.E.</given-names>
            </name>
            <name>
              <surname>McMillen</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Docherty</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Sharpe</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Diraison</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Briscoe</surname>
              <given-names>C.P.</given-names>
            </name>
            <name>
              <surname>Rutter</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis</article-title>
          <source>Am. J. Physiol. Endocrinol. Metab.</source>
          <volume>291</volume>
          <year>2006</year>
          <fpage>E982</fpage>
          <lpage>E994</lpage>
          <pub-id pub-id-type="pmid">16772326</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schreiber</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Matthias</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Schaffner</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Rapid detection of octamer binding proteins with âmini-extractsâ, prepared from a small number of cells</article-title>
          <source>Nucleic Acids Res.</source>
          <volume>17</volume>
          <year>1989</year>
          <fpage>6419</fpage>
          <pub-id pub-id-type="pmid">2771659</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elbashir</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Harborth</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lendeckel</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Yalcin</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Tuschl</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells</article-title>
          <source>Nature</source>
          <volume>411</volume>
          <year>2001</year>
          <fpage>494</fpage>
          <lpage>498</lpage>
          <pub-id pub-id-type="pmid">11373684</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app1" sec-type="supplementary-material">
      <label>Appendix A</label>
      <title>Supplementary data</title>
      <p>
        <supplementary-material content-type="local-data" id="d32e1029">
          <caption>
            <title>Supplementary data 1</title>
            <p>Supplementary material.</p>
          </caption>
          <media xlink:href="mmc1.doc"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="d32e1037">
          <caption>
            <title>Supplementary figures 2</title>
            <p>Supplementary figures.</p>
          </caption>
          <media xlink:href="mmc2.ppt"/>
        </supplementary-material>
      </p>
    </sec>
    <ack>
      <title>Acknowledgments</title>
      <p>G.A.R. thanks the National Institutes of Health for Project grant RO1 DK071962-01, the Wellcome Trust for Programme grants 067081/Z/02/Z and 081958/Z/07/Z, the MRC (UK) for Research Grant G0401641, the EU FP6 (SaveBeta), Imperial College Division of Medicine and the Overseas Research Student Award Scheme (ORSAS) for Rong Anâs PhD studentship. We thank Dr. Isabelle Leclerc for help with EMSA, Dr. Martin Spitaler with confocal imaging, Dr C. Newgard (Duke University) for INS-1 832/13 cells, Dr. Chris Wright (Vanderbilt University) for the anti PDX1 antiserum. L.A.P was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) and European Commission (PROKINASERESEARCH503467). We thank Drs Danielle Melloul (Hadassah University Hospital, Jerusalem), Ulupi Jhala (Whittier Institute, San Diego) for useful discussion and Dr Gargi Meur for proof-reading the manuscript.</p>
    </ack>
    <fn-group>
      <fn id="d32e1012" fn-type="supplementary-material">
        <label>Appendix A</label>
        <p>Supplementary data associated with this article can be found, in the online version, at <ext-link ext-link-type="doi" xlink:href="10.1016/j.bbrc.2010.07.035">doi:10.1016/j.bbrc.2010.07.035</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p>Phosphorylation on Ser-269 is regulated by glucose concentrations in pancreatic islets and MIN6 Î²-cells. (A) Mouse pancreatic islets of Langerhans or (B) MIN6 Î²-cells cultured in medium containing 3Â mM glucose for 1 and 16Â h, respectively. Mouse islets were further cultured for 1Â h at three or 16.7Â mM glucose. MIN6 Î²-cells were further cultured at the indicated glucose concentrations for the indicated time. Nuclear lysates were separated on SDSâPAGE gels and analyzed by Western blot using anti-phospho-Ser-269 PDX1 and anti-PDX1 antibodies. The blots shown are representative of 3 independent experiments. The ratio of phospho-Ser-269 PDX1 to total PDX1 level are shown graphically (A, B lower panels). â<italic>p</italic>Â &lt;Â 0.05, ââ<italic>p</italic>Â &lt;Â 0.01, ns: non-significant; samples were prepared in triplicate. Mean values from three independent experiments are shown.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>Phosphorylation on Ser-269 by HIPK2 <italic>in vitro</italic> and <italic>in vivo</italic>. (A) 2Â Î¼g of recombinant PDX1-<italic>c</italic>-<italic>myc</italic> wild-type or S269A was mixed with (pmol, picomoles) of HIPK2 and [Î³-<sup>32</sup>P] ATP for 30Â min. Autoradiography shows the radiolabeled PDX1 and HIPK2. Coomassie staining shows the PDX1 protein level. (B) Parallel experiment with cold ATP, analyzed by Western blot using indicated antibodies. MIN6 Î²-cells were cultured in the presence of 1Â nM HIPK2 or scrambled siRNA for 72Â h prior to analysis by real-time PCR using primers against mouse HIPK2 (C) or Western blotting with anti-phospho-Ser-269 PDX1 antibody (D). â<italic>p</italic>Â &lt;Â 0.05, ââ<italic>p</italic>Â &lt;Â 0.01. Data shown are from a minimum of three independent experiments.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p>Wild-type and mutant PDX1 half-life MIN6 Î²-cells were transduced with adenoviruses encoding wild-type <italic>c-myc</italic>-tagged-PDX1 (A) or S269A and S269E mutants (B, C) and their respective protein half-life was measured. Total extracts prepared at the indicated times of chase were immunoprecipitated with anti-<italic>c-myc</italic> antibody. PDX1 protein was detected by fluorography. The intensity of radioactive bands was measured and plotted as a percentage of the initial band intensity (0Â h) with Optiquant in a Cyclone (PerkinâElmer) phospho imager storage system. No significant difference in turnover rate was found between wild-type PDX1 and the mutants. The estimated half-lives of WT PDX1 and mutants S269A, S269E were extrapolated by non linear regression from the exponential decay curve fitted to the data points using SigmaPlot 11.0 (Systat Software Inc., San Jose, CA USA). Data points represent the meanÂ Â±Â SEM of three to four experiments.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Fig. 4</label>
      <caption>
        <p>Ser-269 phosphorylation and PDX1 subnuclear localization (A) Immunocytochemical analysis of the subcellular distribution of PDX1-<italic>c-myc</italic>. MIN6 Î²-cells were transduced with adenoviruses encoding for the indicated PDX1 molecules. Cells were cultured at 3Â mM glucose for 16Â h and then treated with 3 or 20Â mM glucose for 6Â h. <italic>c-myc</italic>-tagged PDX1 was detected using anti-<italic>c-myc</italic> antibody (Roche) and Alexa-568 (Molecular Proves). Nuclear staining was achieved using DAPI. Confocal images were captured using a Leica SP2 upright laser scanning confocal microscope (x63/1.32 oil-immersion lens) equipped with a krypton/argon laser (488 and 568Â nm excitation lines) and UV light. Images were analyzed off-line using Volocity<sup>TM</sup> 4.0 software. Each sample was prepared in triplicate. (B) The average number of cells displaying PDX1 localization predominantly at nuclear periphery is expressed as a percentage of the total number of cells analyzed. Mean values from three independent experiments are shown.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>